Taekyung Chemical Co., Ltd.

KRX:006890.KS

11800 (KRW) • At close May 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

202420232022202120202019201820172016201520142013201220112010200920082007
Revenue 71,116.46270,748.22159,613.47854,066.18747,060.53941,832.10447,441.99148,889.79351,339.55750,912.03653,965.98851,890.97155,839.71453,525.07237,829.31538,090.95235,347.13826,123.517
Cost of Revenue 43,134.58239,123.73136,295.91930,854.7629,168.03230,506.60934,379.54836,405.19836,373.67736,132.55738,810.79537,028.14938,831.45237,192.72224,644.02622,101.43323,644.56618,827.917
Gross Profit 27,981.8831,624.4923,317.55923,211.42717,892.50711,325.49513,062.44312,484.59514,965.8814,779.47915,155.19314,862.82217,008.26216,332.3513,185.28915,989.51911,702.5727,295.6
Gross Profit Ratio 0.3930.4470.3910.4290.380.2710.2750.2550.2920.290.2810.2860.3050.3050.3490.420.3310.279
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 619.073648.43624.871535.214461.604521.363460.927489.598478.211502.052453.578460.546482.396433.535323.689279.184245.025240.149
Selling & Marketing Expenses 7,168.4397,344.3086,386.6465,517.3624,872.6514,609.9464,738.9595,416.1045,496.7334,842.3934,440.1954,124.5984,749.8894,145.6522,609.182,842.7073,015.5892,244.809
SG&A 7,787.5127,992.7387,011.5176,052.5765,334.2555,131.3095,199.8865,905.7025,974.9445,344.4454,893.7734,585.1445,232.2854,579.1872,932.8693,121.8913,260.6142,484.958
Other Expenses 6,488.4645,754.3715,905.4575,023.7584,856.1375,002.782195.223144.169391.728575.12215.269199.523-2.26246.34429.899192.366-29.063263.76
Operating Expenses 14,275.97613,747.10912,916.97411,076.33410,190.39210,134.0919,901.86810,687.33711,204.919,707.348,900.3228,727.63710,112.4988,132.9795,873.7145,943.6815,918.4634,911.964
Operating Income 13,705.90417,877.38210,400.58512,135.0937,702.11530,714.5873,160.5751,797.2583,760.975,072.1386,254.8716,135.1856,895.7638,255.9777,311.57210,045.8365,784.1092,383.636
Operating Income Ratio 0.1930.2530.1740.2240.1640.7340.0670.0370.0730.10.1160.1180.1230.1540.1930.2640.1640.091
Total Other Income Expenses Net 1,371.953,776.3871,637.597841.3532,269.69411,090.1041,432.897-848.4381,075.581,731.1831,472.68-893.3522,209.7151,772.8551,852.1822,101.3131,810.0841,634.299
Income Before Tax 15,077.85421,653.76912,038.18413,981.1839,971.8112,281.5064,593.4721,984.0294,836.5526,803.3227,727.5495,241.8339,105.47810,028.8329,163.75412,147.1497,594.1934,017.935
Income Before Tax Ratio 0.2120.3060.2020.2590.2120.2940.0970.0410.0940.1340.1430.1010.1630.1870.2420.3190.2150.154
Income Tax Expense 2,447.0294,281.6643,305.7013,066.4972,237.3162,458.4081,687.216345.011,016.3021,437.9421,620.5421,072.1871,906.4822,201.9692,049.1812,306.0861,753.054940.435
Net Income 12,615.7817,419.48,867.60710,914.6867,734.4949,823.0972,906.2561,639.0193,820.2495,365.386,107.0074,169.6467,198.9967,826.8637,114.5739,841.0635,841.1383,077.5
Net Income Ratio 0.1770.2460.1490.2020.1640.2350.0610.0340.0740.1050.1130.080.1290.1460.1880.2580.1650.118
EPS 1,113.571,536.93782.4963.01681.1857.74251141329463526359621675613848504265
EPS Diluted 1,113.571,536.93782.4963.01681.1857.74251141329463526359621675613848504265
EBITDA 17,574.03324,239.31214,322.94515,871.3389,984.88314,934.4655,718.0364,286.6586,135.0587,452.3088,635.3278,431.87810,902.80712,342.21510,904.77713,773.3019,595.5985,815.393
EBITDA Ratio 0.2470.3430.240.2940.2120.3570.1210.0880.1190.1460.160.1620.1950.2310.2880.3620.2710.223